Publications:

A. Articles Published in International Peer-Reviewed Journals:

• Demircan Nazim Can, Atcı Muhammed Mustafa, et al. “Dynamic changes in systemic immune‐inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy.” Asia-Pacific Journal of Clinical Oncology.
• Gürsoy Pınar, Tatlı Ali Murat, et al. “Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.” Journal of Cancer Research and Clinical Oncology.
• Atcı Muhammed Mustafa, Akagündüz Baran, et al. “The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study.” Journal of Chemotherapy.
• Bozkurt Muammer, Aghalarov Samir, Atcı Muhammed Mustafa, et al. “A new biomarker for lung metastasis in non-seminomatous testicular cancer: De Ritis Ratio.” Aktuelle Urologie.
• Aktürk Esen Selin, Ergün Yakup, et al. “First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma.” Biomolecules and Biomedicine.
• Çil İbrahim, Küçükarda Ahmet, Atcı Muhammed Mustafa, et al. “Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study.” Tumori Journal.
• Göktaş Aydın Sabin, Çakan Demirel Burçin, et al. “Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer.” Current Medical Research and Opinion.
• Hızal Mutlu, Bilgin Burak, et al. “Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small cell lung cancer patients: a Turkish Oncology Group study.” Future Oncology.
• Dülgar Özgecan, Öven Başak Bala, Atcı Muhammed Mustafa, et al. “Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?” Expert Review of Anticancer Therapy.
• Özdemir Özlem, Zengel Baha, et al. “The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.” Anti-Cancer Drugs.
• Atcı Muhammed Mustafa, Akagündüz Baran, et al. “Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study.” Oncology Research and Treatment.
• Ay Ersoy Seval, Atcı Muhammed Mustafa, et al. “FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.” Journal of Chemotherapy.
• Atcı Muhammed Mustafa, Pamukçu Cerciz Özgül, et al. “The relationship between poor glycaemic control and risk factors in patients with type 2 diabetes mellitus.” Eurasian Journal of Medical Advances.
• Atcı Muhammed Mustafa, Sakin Abdullah, et al. “Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer.” JCPSP – Journal of The College of Physicians and Surgeons Pakistan.
• Arıcı Serdar, Hamdard Jamshid, et al. “The conversion of RAS status in metastatic colorectal cancer patients after first‐line biological agent treatment.” Colorectal Disease.
• Sezgin Göksu Sema, Tatlı Ali Murat, et al. “Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck.” Cancer Chemotherapy and Pharmacology.
• Akagündüz Baran, Demir Metin, Atcı Muhammed Mustafa. “Controlling Nutritional Status (CONUT) Score Is a Prognostic Factor for Patients with Gastric Cancer Treated by Perioperative FLOT.” Journal of Gastrointestinal Cancer.
• Topçu Atakan, Atcı Muhammed Mustafa, et al. “Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.” Future Oncology.
• Akagündüz Baran, Altın Zeynep, Atcı Muhammed Mustafa, et al. “Assessment of abuse and related factors in older patients with cancer.” Supportive Care in Cancer.
• Akagündüz Baran, Özer Muhammet, et al. “Impact of coronaphobia on treatment and follow-up compliance of cancer patients.” Future Oncology.
• Arıcı Serdar, Sağlampınar Karyağar Sevda, et al. “The correlation between tumor markers and Ga-68 DOTA-TATE PET/CT findings in patients with advanced medullary thyroid cancer.” Revista Española de Medicina Nuclear e Imagen Molecular.
• Atcı Muhammed Mustafa, Geredeli Çağlayan, et al. “Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study.” European Journal of Breast Health.
• Sakin Abdullah, Atcı Muhammed Mustafa, et al. “The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy.” Cureus, Inc.
• Sakin Abdullah, Şahin Süleyman, et al. “The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.” Journal of Gastrointestinal Cancer.
• Arıcı Serdar, Şengiz Erhan Selma, et al. “The Prognostic Importance of Microsatellite Instability Status in Turkish Stage II and III Gastric Cancer Patients who Received Adjuvant Chemotherapy.” International Journal of Hematology and Oncology.
• Sakin Abdullah, Şahin Süleyman, Atcı Muhammed Mustafa, et al. “The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer.” Pulmonology.
• Sakin Ayşegül, Şahin Süleyman, Sakin Abdullah, et al. “Effect of type 2 diabetes mellitus on survival in metastatic pancreatic cancer.” Journal of Surgery and Medicine (JOSAM).
• Akagündüz Baran, Akın Telli Tuğba, et al. “Factors Affecting Survival in Retroperitoneal Sarcomas Treated with Upfront Surgery: A Real-World Study by Turkish Oncology Group.” International Journal of Hematology and Oncology.
• Sakin Ayşegül, Şahin Süleyman, Atcı Muhammed Mustafa, et al. “The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy.” Nutrition and Cancer.
• Sakin Ayşegül, Şahin Süleyman, Sakin Abdullah, et al. “Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis.” Journal of BUON.
• Sakin Abdullah, Şahin Süleyman, Sakin Ayşegül, et al. “Factors affecting survival in operated pancreatic cancer; Does tumor localization have a significant effect on treatment outcomes?” Northern Clinics of Istanbul.
• Arıcı Serdar, Sağlampınar Karyağar Sevda, et al. “The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer.” Journal of Oncology Pharmacy Practice.
• Sakin Abdullah, Yılmaz Ürün Yonca, et al. “Factors Affecting Survival in Esophageal Squamous Cell Carcinoma: Single Center Experience.” Northern Clinics of Istanbul.
• Sakin Abdullah, Şahin Süleyman, Atcı Muhammed Mustafa, et al. “Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis.” Journal of BUON.

B. Proceedings Presented at International Scientific Meetings:

• Senocak Tasci Elif, et al. “Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish Oncology Group study.” (2022 ASCO Gastrointestinal Cancers Symposium, Abstract/Poster)
• Arıcı Serdar, Çekin Ruhper, Atcı Muhammed Mustafa. “ANDROGEN RECEPTOR STATUS IN TURKISH PATIENTS WITH HORMONE RECEPTOR POSITIVE LOCAL AND LOCALLY ADVANCED BREAST CANCER.” (6th Congress of the Mediterranean Multidisciplinary Oncology Forum & 3rd International Congress on Oncological Sciences, Abstract/Oral Presentation)

C. National/International Books or Book Chapters

C2. Chapters in National/International Books:

• Atcı Muhammed Mustafa. “APPROACH AND FOLLOW-UP IN MEDULLARY THYROID CANCER.” In A Multidisciplinary Approach to Thyroid Gland and Diseases. AKADEMİSYEN YAYINEVİ.
• Atcı Muhammed Mustafa. “Small Cell Lung Cancers.” In Targeted Therapies in Oncology with Clinical Studies. Hipertıp Yayınevi.
• Atcı Muhammed Mustafa. “Hormone Receptor Positive Breast Cancers.” In Targeted Therapies in Oncology with Clinical Studies. Hipertıp Yayınevi.
• D. Articles Published in National Peer-Reviewed Journals
• Ay Ersoy Seval, Atcı Muhammed Mustafa, et al. “Initial Albumin-Bilirubin Grade as a Prognostic Indicator of Pancreatic Cancer with Liver Metastasis.” Journal of Oncological Sciences.
• Topçu Atakan, Beşiroğlu Mehmet, Atcı Muhammed Mustafa, et al. “Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data.” Eurasian Journal of Medical Investigation (EJMI).
• Ay Ersoy Seval, Tataroğlu Özyükseler Deniz, et al. “Second Line Treatment Choice in Extensive Small Lung Cancer.” Eurasian Journal of Medical Investigation (EJMI).
• Günay Semra, Pussane Ali Murat, et al. “Effects of a COVID-19 Pandemic on Breast Cancer Management.” European Archives of Medical Research.
• Atcı Muhammed Mustafa, Can Orçun, et al. “Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study.” Journal of Oncological Sciences.
• Akagündüz Baran, Güven Deniz Can, Atcı Muhammed Mustafa, et al. “Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists.” Journal of Oncological Sciences (JOS).
• Atcı Muhammed Mustafa, Çekin Ruhper. “Predictive Importance of Vitamin D on Response to Neoadjuvant Chemotherapy in Turkish Patients with Locally Advanced Hormone Receptor Positive Breast Cancer.” Eurasian Journal of Medical Investigation (EJMI).
• Arıcı Serdar, Çekin Ruhper, et al. “The clinical importance of fibroblast growth factor 23 on advanced non-small cell lung cancer patients without druggable alterations in genes such as EGFR, ALK, or ROS1.” Eurasian Journal of Medical Investigation (EJMI).
• Sakin Abdullah, Şahin Süleyman, Atcı Muhammed Mustafa, et al. “The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status.” Journal of Oncological Sciences (JOS).

E. Proceedings Presented at National Scientific Meetings:

• Atcı Muhammed Mustafa. “NSCLC Treatment Algorithm: Neoadjuvant and Adjuvant Treatment Options.” (National Lung Health Congress, Abstract/Invited Speaker)
• Dizdar Ömer, Kazaz Seher Nazlı, Atcı Muhammed Mustafa. “MULTIDISCIPLINARY TUMOR BOARD: NON-TUBULAR GIS TUMORS.” (9th Turkish Medical Oncology Congress, Abstract/Invited Speaker)
• Atcı Muhammed Mustafa. “Evaluation of Pazopanib Effectiveness in Metastatic Soft Tissue Sarcomas: Single-Center Experience.” (5th Congress on Oncology with Young Professionals, Abstract/Oral Presentation)
• Hızal Mutlu, Bilgin Burak, et al. “Assessment of Efficacy and Safety of First-Line Alectinib Treatment in ALK Mutant Advanced NSCLC (TOG).” (8th Turkish Medical Oncology Congress, Abstract/Oral Presentation)
• Özdemir Özlem, Zengel Baha, et al. “Efficacy and Safety of Neoadjuvant Pertuzumab and Trastuzumab in Women with HER2-Positive Breast Cancer: TOG Study.” (8th Turkish Medical Oncology Congress, Abstract/Oral Presentation)
• Atcı Muhammed Mustafa. “Importance of Expected Survival in Treatment Selection for Cancer Patients.” (8th Turkish Medical Oncology Congress, Abstract/Oral Presentation)
• Sakin Abdullah, Şahin Süleyman, Sakin Ayşegül, et al. “Factors Affecting Survival in Pancreatic Cancer; Does Tumor Localization Impact Treatment Outcomes?” (8th Turkish Medical Oncology Congress, Abstract/Oral Presentation)
• Gürsoy Pınar, Tatlı Ali Murat, et al. “Efficacy of Tyrosine Kinase Inhibitors in Patients with Exon 18 and Exon 20 Mutations.” (8th Turkish Medical Oncology Congress, Abstract/Oral Presentation)
• Almuradova Elvina, Başoğlu Tüylü Tuğba, et al. “Sarcomatoid Renal Cell Carcinoma: Turkish Real-Life Data.” (8th Turkish Medical Oncology Congress, Abstract/Oral Presentation)
• Atcı Muhammed Mustafa. “Single-Center Experience with Nivolumab in Renal Cell Cancer Treatment.” (4th National Immunotherapy and Oncology Congress, Abstract/Oral Presentation)
• Atcı Muhammed Mustafa. “Efficacy of Axitinib in Second-Line Metastatic Renal Cell Cancer: Single-Center Experience.” (Oncology Innovations During COVID-19 E-Symposium, Abstract/Oral Presentation)
• Atcı Muhammed Mustafa. “The Role of Tyrosine Kinase Inhibitors in the Treatment of Advanced Medullary Thyroid Cancer.” (3rd National Immunotherapy and Oncology Congress, Abstract/Oral Presentation)
• Atcı Muhammed Mustafa, Geredeli Çağlayan. “Demographic Characteristics of Patients with BRCA Mutation After Breast Cancer Diagnosis.” (Current Developments in Cancer: Breast Cancer Symposium, Abstract/Oral Presentation)
• Atcı Muhammed Mustafa, Sağlampınar Karyağar Sevda. “Relationship Between TSH and Tumor Load in Metastatic Medullary Thyroid Cancer.” (2nd Internal Medicine Congress, Health Sciences University, Full-Text Presentation/Oral Presentation)